Artisan Bio to highlight CRISPR platform at Cell & Gene Meeting
By The Science Advisory Board staff writersOctober 11, 2021
The company's STAR platform consists of a family of endonuclease-based editing systems to produce cell therapy design candidates. Artisan Bio has validated the platform with T cells, induced pluripotent stem cells and cancer cells, as well as industrial cell lines like CHO and HEK293, it said.